Kyverna Therapeutics Requests to Dismiss Class Action Filed by Investors

Court: N.D. California

Case: 5:24-cv-08869

Kyverna Therapeutics has requested the court to dismiss the lawsuit filed by investors. The court will determine whether the case proceeds.

What is this lawsuit about?

On June 14, 2024, Kyverna revealed negative trial data at an industry conference, contradicting its earlier positive IPO statements.

Following this, KYTX dropped by 25%.

Then, on December 9, 2024, shareholders filed a claim against Kyverna Therapeutics.

What can you do to recover your losses now?

We’re keeping track of all updates and will notify KYTX investors about potential recovery.

More than 600 companies are currently facing securities class action lawsuits, and over 100 are already paying settlements. Connect your brokerage account to automatically check which ones you may have missed.